These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21557146)

  • 1. Epilepsy with myoclonic absences - favourable response to add-on rufinamide treatment in 3 cases.
    Häusler M; Kluger G; Nikanorova M
    Neuropediatrics; 2011 Feb; 42(1):28-9. PubMed ID: 21557146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome).
    von Stülpnagel C; Coppola G; Striano P; Müller A; Staudt M; Kluger G
    Eur J Paediatr Neurol; 2012 Sep; 16(5):459-63. PubMed ID: 22266062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy.
    Kim SH; Lee JH; Ryu HW; Lim BC; Chae JH; Choi JE; Hwang YS; Kim KJ
    Epileptic Disord; 2013 Mar; 15(1):49-54. PubMed ID: 23531645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with rufinamide in a pediatric population: a single center's experience.
    Vendrame M; Loddenkemper T; Gooty VD; Takeoka M; Rotenberg A; Bergin AM; Eksioglu YZ; Poduri A; Duffy FH; Libenson M; Bourgeois BF; Kothare SV
    Pediatr Neurol; 2010 Sep; 43(3):155-8. PubMed ID: 20691934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rufinamide: a new antiepileptic drug treatment for Lennox-Gastaut syndrome.
    Ferrie CD
    Expert Rev Neurother; 2010 Jun; 10(6):851-60. PubMed ID: 20518600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.
    Wisniewski CS
    Ann Pharmacother; 2010 Apr; 44(4):658-67. PubMed ID: 20233912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of rufinamide in drug-resistant epilepsy: a meta-analysis.
    Verrotti A; Loiacono G; Ballone E; Mattei PA; Chiarelli F; Curatolo P
    Pediatr Neurol; 2011 May; 44(5):347-9. PubMed ID: 21481742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rufinamide. An orphan drug for treatment of Lennox-Gastaut syndrome].
    Kreutzkamp B
    Med Monatsschr Pharm; 2007 Oct; 30(10):358-61. PubMed ID: 17966284
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study.
    Kluger G; Glauser T; Krauss G; Seeruthun R; Perdomo C; Arroyo S
    Acta Neurol Scand; 2010 Sep; 122(3):202-8. PubMed ID: 20199521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome.
    Mueller A; Boor R; Coppola G; Striano P; Dahlin M; von Stuelpnagel C; Lotte J; Staudt M; Kluger G
    Epilepsy Behav; 2011 Jul; 21(3):282-4. PubMed ID: 21620771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience.
    Coppola G; Grosso S; Franzoni E; Veggiotti P; Zamponi N; Parisi P; Spalice A; Habetswallner F; Fels A; Capovilla G; Verrotti A; Mangano S; Balestri A; Curatolo P; Pascotto A
    Seizure; 2010 Nov; 19(9):587-91. PubMed ID: 20888268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.
    Coppola G; Besag F; Cusmai R; Dulac O; Kluger G; Moavero R; Nabbout R; Nikanorova M; Pisani F; Verrotti A; von Stülpnagel C; Curatolo P
    Eur J Paediatr Neurol; 2014 Nov; 18(6):685-90. PubMed ID: 24929673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases.
    Vendrame M; Poduri A; Loddenkemper T; Kluger G; Coppola G; Kothare SV
    Epileptic Disord; 2011 Mar; 13(1):18-21. PubMed ID: 21393094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of rufinamide in children under four years of age with drug-resistant epilepsies.
    Grosso S; Coppola G; Dontin SD; Gobbi G; Pruna D; Accorsi P; Verrotti A; Parisi P; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):641-5. PubMed ID: 24912730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and prognosis of a short course of prednisolone therapy for pediatric epilepsy.
    You SJ; Jung DE; Kim HD; Lee HS; Kang HC
    Eur J Paediatr Neurol; 2008 Jul; 12(4):314-20. PubMed ID: 17951084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.
    Striano P; McMurray R; Santamarina E; Falip M
    Epileptic Disord; 2018 Feb; 20(1):13-29. PubMed ID: 29313492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe myoclonic epilepsy in infancy (Dravet's syndrome). Its nosological characteristics and therapeutic aspects].
    Nieto Barrera M; Candau Fernandez Mensaque R; Nieto Jiménez M
    Rev Neurol; 2003 Jul 1-15; 37(1):64-8. PubMed ID: 12861512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.
    Nikanorova M; Brandt C; Auvin S; McMurray R
    Epilepsy Behav; 2017 Nov; 76():63-70. PubMed ID: 28927712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.